Atlanta, GA, United States of America

Angela Driver-Scott

This inventor holds 3 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Alcon, Inc., Novartis Ag. Active years: 2020-2022.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Contact Lens Technology by Angela Driver-Scott

Introduction

Angela Driver-Scott is a prominent inventor based in Atlanta, GA, known for her significant contributions to the field of contact lens technology. With a total of three patents to her name, she has developed innovative methods that enhance the comfort and functionality of contact lenses.

Latest Patents

One of her latest patents is a process for producing contact lenses with durable lubricious coatings. This invention relates to a method for creating soft contact lenses that feature a silicone hydrogel lens body and a composite coating. The composite coating includes a plasma base coating that is chemically attached to the silicone hydrogel surface, providing a fail-proof measure to protect the lens material from exposure to ocular environments for at least 30 days of daily use. Additionally, a durable lubricious hydrogel top coating ensures wearing comfort. The method involves forming a plasma-reactive hydrophilic polymer hybrid base coating on the silicone hydrogel lens and heating it in an aqueous solution to create a stable lubricious hydrogel coating, minimizing any adverse impact on the mechanical properties of the lens.

Another notable patent is for producing MPS-compatible water gradient contact lenses. This invention focuses on a process that results in contact lenses with water gradient structural configurations, which also minimize the uptake of polyquaternium-1. The lenses maintain long-lasting surface hydrophilicity and wettability, even after undergoing a simulated 30-day lens care regime

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…